Biomarkers Analysis of COVID-19 Patients: Lessons Learnt from the Deadly Pandemic
No Thumbnail Available
Date
2024-05
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Society for Scientific Research
Abstract
Background: Coronavirus disease-2019 (COVID-19) manifests as inflammation, leading to a raised level of associated biomarkers, which assists in risk stratification. We investigated the correlation between demography and biomarkers, namely, Interleukin-6 (IL-6), serum C-reactive protein (CRP), D-dimer, procalcitonin (PCT), and serum ferritin with prognosis among COVID-19 patients. Method: This is a retrospective cohort study conducted on COVID-19 patients amidst the second wave of the pandemic. IL-6, PCT, serum ferritin, CRP, and D-dimer levels were analyzed among patients diagnosed as COVID-positive by real-time polymerase chain reaction. Result: Out of 1663 patients included in this study, 65% were males, with the median age of the study population being 48 years. The mean levels of IL-6, ferritin, CRP, and PCT were significantly raised in the older age group (47-95 years) than the younger population (4-46 years), whereas D-dimer was found to be raised in all age groups. The mortality rate was 5% (median age- 59 years), with males showing high severity and a mortality rate 67.4%. Conclusion: Evaluating and tracking the biomarkers at the outset of the disease has been proven to give a substantial edge in assessing disease prognosis and preventing mortality. Henceforth, they become the guiding force for management strategies in this era of precision medicine.
Description
Keywords
Coronavirus, Immunosenescence, Inflammation, Precision medicine, Prognostic markers
Citation
Bisen VV, Upadhyay S, Patel M, Singh A. Biomarkers Analysis of COVID-19 Patients: Lessons Learnt from the Deadly Pandemic. SSR Institute of International Journal of Life Sciences. 2024 May; 10(3): 5486-5491